LA SR217 | 2021 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on June 10 2021 - 100% progression
Action: 2021-06-10 - Enrolled. Signed by the President of the Senate and sent to the Secretary of State by the Secretary of the Senate on 6/14/2021.
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on June 10 2021 - 100% progression
Action: 2021-06-10 - Enrolled. Signed by the President of the Senate and sent to the Secretary of State by the Secretary of the Senate on 6/14/2021.
Text: Latest bill text (Enrolled) [PDF]
Summary
Directs the Louisiana Department of Health and the LSU Health Services Center - New Orleans, health care services division, to report on the use and results of hydroxychloroquine on Medicaid patients for treating COVID-19.
Title
Directs the Louisiana Department of Health and the LSU Health Services Center - New Orleans, health care services division, to report on the use and results of hydroxychloroquine on Medicaid patients for treating COVID-19.
Sponsors
Roll Calls
2021-06-10 - Senate - Senate Vote on SR 217 ADOPT (#1123) (Y: 22 N: 13 NV: 0 Abs: 3) [PASS]
History
Date | Chamber | Action |
---|---|---|
2021-06-10 | Senate | Enrolled. Signed by the President of the Senate and sent to the Secretary of State by the Secretary of the Senate on 6/14/2021. |
2021-06-10 | Senate | By a vote of 22 yeas and 13 nays. |
2021-06-10 | Senate | Senate amendments read and adopted. Read by title and adopted. |
2021-06-09 | Senate | Rules suspended. Introduced in the Senate. Read by title and placed on the Calendar for a second reading. |